MXPA03009021A - Composicion antifungal con biodisponibilidad aumentada. - Google Patents

Composicion antifungal con biodisponibilidad aumentada.

Info

Publication number: MXPA03009021A
Authority: MX; Mexico
Prior art keywords: antifungal composition; enhanced bioavailability; bioavailability; enhanced; antifungal
Prior art date: 2001-04-03

Application number

MXPA03009021A

Other languages

English (en)

Inventor

David Harris

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-03

Filing date

2002-04-01

Publication date

2004-02-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23076102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03009021(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-04-01 Application filed by Schering Corp filed Critical Schering Corp

2004-02-12 Publication of MXPA03009021A publication Critical patent/MXPA03009021A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Dentistry (AREA)
Zoology (AREA)
Environmental Sciences (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Plant Pathology (AREA)
Pest Control & Pesticides (AREA)
Agronomy & Crop Science (AREA)
Dispersion Chemistry (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

MXPA03009021A 2001-04-03 2002-04-01 Composicion antifungal con biodisponibilidad aumentada. MXPA03009021A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28113901P	2001-04-03	2001-04-03
PCT/US2002/010093 WO2002080678A1 (en)	2001-04-03	2002-04-01	Antifungal composition with enhanced bioavailability

Publications (1)

Publication Number	Publication Date
MXPA03009021A true MXPA03009021A (es)	2004-02-12

Family

ID=23076102

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03009021A MXPA03009021A (es)	2001-04-03	2002-04-01	Composicion antifungal con biodisponibilidad aumentada.

Country Status (18)

Country	Link
US (2)	US20030055067A1 (es)
EP (2)	EP2090165A3 (es)
JP (2)	JP4308902B2 (es)
KR (1)	KR100607742B1 (es)
CN (1)	CN100415234C (es)
AR (1)	AR033096A1 (es)
AU (1)	AU2002257104B2 (es)
BR (1)	BR0208626A (es)
CA (1)	CA2443089C (es)
HU (1)	HUP0400856A3 (es)
MX (1)	MXPA03009021A (es)
NO (1)	NO20034419L (es)
NZ (1)	NZ528363A (es)
PE (1)	PE20020994A1 (es)
PL (1)	PL212985B1 (es)
TW (1)	TWI311464B (es)
WO (1)	WO2002080678A1 (es)
ZA (1)	ZA200307684B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9700866B2 (en)	2000-12-22	2017-07-11	Baxter International Inc.	Surfactant systems for delivery of organic compounds
US20030072807A1 (en) *	2000-12-22	2003-04-17	Wong Joseph Chung-Tak	Solid particulate antifungal compositions for pharmaceutical use
US8067032B2 (en)	2000-12-22	2011-11-29	Baxter International Inc.	Method for preparing submicron particles of antineoplastic agents
US7193084B2 (en)	2000-12-22	2007-03-20	Baxter International Inc.	Polymorphic form of itraconazole
BR0212833A (pt)	2001-09-26	2004-10-13	Baxter Int	Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
EP1761247A1 (en) *	2004-05-28	2007-03-14	Schering Corporation	Injectable pharmaceutical suspension comprising posaconazole
US20060009469A1 (en) *	2004-05-28	2006-01-12	Leonore Witchey-Lakshmanan	Particulate-stabilized injectable pharmacutical compositions of posaconazole
US20060160823A1 (en) *	2004-05-28	2006-07-20	Leonore Witchey-Lakshmanan	Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
US7473684B2 (en) *	2005-09-16	2009-01-06	Selamine Limited	Bisphosphonate formulation
SG170047A1 (en)	2006-05-30	2011-04-29	Elan Pharma Int Ltd	Nanoparticulate posaconazole formulations
AR061351A1 (es)	2006-06-14	2008-08-20	Intervet Int Bv	Composicion de carbamato de bencimidazol
GB0624084D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril amino acid salts
GB0624090D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril amine salts
GB0624087D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril combination salt
FR2910323A1 (fr) *	2006-12-26	2008-06-27	Virbac Sa Sa	Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
DE102008004893A1 (de)	2008-01-17	2009-07-23	Add Technologies Ltd.	Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
JP2011516613A (ja) *	2008-04-15	2011-05-26	シェーリングコーポレイション	好ましくはポサコナゾールおよびｈｐｍｃａｓを含む固体分散物中の経口用薬学的組成物
CN102065842A (zh) *	2008-04-15	2011-05-18	先灵公司	优选含有泊沙康唑和hpmcas的固体分散体形式的口服药物组合物
EP2130540A1 (en)	2008-06-02	2009-12-09	Sandoz AG	Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en)	2008-07-03	2010-01-06	Sandoz AG	A Crystalline form of posaconazole
US20120101277A1 (en)	2009-07-09	2012-04-26	Sandoz Ag	Crystalline form of posaconazole
EP2571869B1 (en)	2010-05-19	2015-09-23	Sandoz AG	Purification of posaconazole and posaconazole intermediates
EP2571871B1 (en)	2010-05-19	2017-06-21	Sandoz AG	Process for the preparation of chiral triazolones
CN102892762B (zh)	2010-05-19	2016-04-20	桑多斯股份公司	制备泊沙康唑中间体
CN102892750B (zh)	2010-05-19	2016-03-02	桑多斯股份公司	制备手性酰肼的方法
WO2012172015A1 (en)	2011-06-16	2012-12-20	Sandoz Ag	Process for the preparation of a chiral compound
CN104379132A (zh)	2012-06-14	2015-02-25	桑多斯股份公司	包含结晶泊沙康唑的药物组合物
EA033736B1 (ru)	2014-12-05	2019-11-20	Pulmocide Ltd	Антимикотическое соединение
CN107635988B (zh) *	2015-05-21	2021-06-18	普尔莫赛德有限公司	抗真菌的苯甲酰胺类衍生物或其可药用盐
CN105030668B (zh) *	2015-06-26	2018-03-27	济川药业集团有限公司	泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) *	2015-07-10	2019-06-18	上海美悦生物科技发展有限公司	一种泊沙康唑液体混悬剂及其制备方法
EA038421B1 (ru) *	2015-12-30	2021-08-26	ВиПиЭс-3, ИНК.	Соединения, ингибирующие металлоферменты
CN106389390A (zh) *	2016-06-30	2017-02-15	重庆华邦制药有限公司	泊沙康唑涂膜剂及其制备方法
CN107625729A (zh) *	2017-09-29	2018-01-26	重庆华邦制药有限公司	泊沙康唑口服混悬液及其制备方法
CN110507609B (zh) *	2018-05-21	2021-09-17	上海医药工业研究院	泊沙康唑口服混悬剂的制备方法
GB201917867D0 (en)	2019-12-06	2020-01-22	Pulmocide Ltd	Polymorphs
WO2021229359A2 (en) *	2020-05-12	2021-11-18	Cellix Bio Private Limited	Process for the preparation salts of triazole compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4533254A (en)	1981-04-17	1985-08-06	Biotechnology Development Corporation	Apparatus for forming emulsions
US4788220A (en) *	1987-07-08	1988-11-29	American Home Products Corporation (Del.)	Pediatric ibuprofen compositions
NZ234143A (en) *	1989-06-28	1991-10-25	Mcneil Ppc Inc	Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5145684A (en) *	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
US5399363A (en)	1991-01-25	1995-03-21	Eastman Kodak Company	Surface modified anticancer nanoparticles
US5552160A (en)	1991-01-25	1996-09-03	Nanosystems L.L.C.	Surface modified NSAID nanoparticles
AU642066B2 (en)	1991-01-25	1993-10-07	Nanosystems L.L.C.	X-ray contrast compositions useful in medical imaging
US5661151A (en)	1993-12-21	1997-08-26	Schering Corporation	Tetrahydrofuran antifungals
JP2834889B2 (ja)	1993-12-21	1998-12-14	シェーリングコーポレイション	テトラヒドロフラン抗真菌剤
GB9405304D0 (en) *	1994-03-16	1994-04-27	Scherer Ltd R P	Delivery systems for hydrophobic drugs
US5580579A (en) *	1995-02-15	1996-12-03	Nano Systems L.L.C.	Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
EP0862917A4 (en) *	1995-11-20	2002-01-09	Banyu Pharma Co Ltd	ANTIFUNGAL COMPOSITION
US5834472A (en)	1996-05-24	1998-11-10	Schering Corporation	Antifungal composition with enhanced bioavailability
US5846971A (en)	1996-06-28	1998-12-08	Schering Corporation	Oral antifungal composition
WO1998051281A1 (en) *	1997-05-14	1998-11-19	Senju Pharmaceutical Co., Ltd.	Aqueous suspension preparations with excellent redispersibility
WO1999061001A1 (en)	1998-05-29	1999-12-02	Rtp Pharma Inc.	Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
US20050048126A1 (en) *	2000-12-22	2005-03-03	Barrett Rabinow	Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

2002
- 2002-04-01 CN CNB028077407A patent/CN100415234C/zh not_active Expired - Lifetime
- 2002-04-01 EP EP09158184A patent/EP2090165A3/en not_active Withdrawn
- 2002-04-01 WO PCT/US2002/010093 patent/WO2002080678A1/en not_active Ceased
- 2002-04-01 CA CA2443089A patent/CA2443089C/en not_active Expired - Lifetime
- 2002-04-01 NZ NZ528363A patent/NZ528363A/en not_active IP Right Cessation
- 2002-04-01 BR BR0208626-3A patent/BR0208626A/pt not_active Application Discontinuation
- 2002-04-01 PL PL363965A patent/PL212985B1/pl unknown
- 2002-04-01 US US10/114,612 patent/US20030055067A1/en not_active Abandoned
- 2002-04-01 KR KR1020037012936A patent/KR100607742B1/ko not_active Expired - Lifetime
- 2002-04-01 JP JP2002578726A patent/JP4308902B2/ja not_active Expired - Lifetime
- 2002-04-01 HU HU0400856A patent/HUP0400856A3/hu not_active Application Discontinuation
- 2002-04-01 AU AU2002257104A patent/AU2002257104B2/en not_active Expired
- 2002-04-01 EP EP02726689A patent/EP1372394A1/en not_active Ceased
- 2002-04-01 MX MXPA03009021A patent/MXPA03009021A/es active IP Right Grant
- 2002-04-02 PE PE2002000263A patent/PE20020994A1/es active IP Right Grant
- 2002-04-02 TW TW091106644A patent/TWI311464B/zh not_active IP Right Cessation
- 2002-04-02 AR ARP020101198A patent/AR033096A1/es not_active Application Discontinuation
2003
- 2003-10-01 ZA ZA2003/07684A patent/ZA200307684B/en unknown
- 2003-10-02 NO NO20034419A patent/NO20034419L/no not_active Application Discontinuation
2008
- 2008-02-18 JP JP2008036719A patent/JP2008120836A/ja active Pending
2011
- 2011-06-15 US US13/161,097 patent/US8263600B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20030055067A1 (en)	2003-03-20
HUP0400856A2 (hu)	2004-08-30
CN100415234C (zh)	2008-09-03
KR100607742B1 (ko)	2006-08-01
CN1499930A (zh)	2004-05-26
AU2002257104B2 (en)	2006-02-09
WO2002080678A1 (en)	2002-10-17
NO20034419L (no)	2003-12-02
US20110244004A1 (en)	2011-10-06
EP1372394A1 (en)	2004-01-02
HUP0400856A3 (en)	2012-09-28
CA2443089C (en)	2011-11-01
PL363965A1 (en)	2004-11-29
EP2090165A3 (en)	2012-03-28
NZ528363A (en)	2005-04-29
PE20020994A1 (es)	2002-11-01
BR0208626A (pt)	2004-03-09
TWI311464B (en)	2009-07-01
PL212985B1 (pl)	2012-12-31
JP4308902B2 (ja)	2009-08-05
JP2008120836A (ja)	2008-05-29
CA2443089A1 (en)	2002-10-17
AR033096A1 (es)	2003-12-03
JP2004527525A (ja)	2004-09-09
KR20030087052A (ko)	2003-11-12
US8263600B2 (en)	2012-09-11
EP2090165A2 (en)	2009-08-19
NO20034419D0 (no)	2003-10-02
ZA200307684B (en)	2005-03-30

Publication	Publication Date	Title
MXPA03009021A (es)	2004-02-12	Composicion antifungal con biodisponibilidad aumentada.
MXPA03007093A (es)	2003-11-18	Nueva composicion.
MXPA03009558A (es)	2004-02-12	Compuestos novedosos.
ZA200208561B (en)	2003-05-19	Hydraulischer druckverstarker.
MXPA02001855A (es)	2003-07-14	Composicion mejorada de revestimiento.
IL157334A0 (en)	2004-02-19	Topical composition comprising an antifungal
ZA200308717B (en)	2004-05-26	Herbicidal composition.
MXPA01009037A (es)	2003-11-18	I-bet.
ZA200305185B (en)	2004-07-13	Anti-microbial composition.
MXPA03009698A (es)	2004-01-29	Vacuna multivalente que comprende un antigeno vih y un antigeno vsh y/o un antigeno vph.
MXPA03007693A (es)	2003-12-04	Composicion para la piel.
MXPA03005286A (es)	2003-10-06	METODO Y APARATO PARA SUPERVISAR PULSACION DE INSTALACION DE ORDEnA.
MXPA03007539A (es)	2003-12-04	Composicion herbicida.
MXPA03008139A (es)	2003-12-12	Fluoralcoxifenilsulfonilureas sustituidas.
MXPA03009002A (es)	2004-02-12	5-halogeno-6-fenil-7-fluoroalquilamino-triazolopirimidinas.
EG23378A (en)	2005-02-28	Composition.
MXPA03005634A (es)	2003-10-06	Mezclas fungicidas.
MXPA03008077A (es)	2003-12-12	Composicion humedecedora para la piel..
MXPA03005758A (es)	2003-09-10	Mezclas fungicidas.
MXPA03009409A (es)	2004-01-29	Composicion herbicida.
MXPA03004242A (es)	2003-09-22	Nuevas fenilpiperazinas.
AU2002367173A8 (en)	2003-07-15	Antifungal compositions
AP2004003017A0 (en)	2004-06-30	Fungicidal mixtures.
HK1057148A (en)	2004-03-19	Antifungal composition with enhanced bioavailability
MXPA03006632A (es)	2003-10-15	Composicion solida.

Legal Events

Date	Code	Title	Description
2011-10-21	FG	Grant or registration
2012-09-14	HC	Change of company name or juridical status